In healthy volunteers, the transient glycaemia observed following glucagon injection is due to increased glycogenolysis (van Kempen et al. 2005); this increase in glycogenolysis is attenuated in patients with cirrhosis, even when they are glycogen replete (Bugianesi et al. 1998). The gene discussed is GCG; the disease is Cirrhosis.